Hydroxychloroquine Drugs Market - Global Industry Analysis, Size, Trends, Growth, Trends, and Forecast 2019-2027
Sr. No. Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8 Chapter 9 Chapter 10 Chapter 11 Chapter 12 Chapter 13 Chapter 14 Content Preface Assumptions and Research Methodology Market Overview Market Dynamics Global Hydroxychloroquine Drugs Market Analysis and Forecasts, By Software Type Global Hydroxychloroquine Drugs Market Analysis, by Modality Global Hydroxychloroquine Drugs Market Analysis, by Application Global Hydroxychloroquine Drugs Market Analysis, by End-user Global Hydroxychloroquine Drugs Market Analysis and Forecast by Region Europe Hydroxychloroquine Drugs Market Analysis and Forecast Asia Pacific Hydroxychloroquine Drugs Market Analysis and Forecast Latin America Hydroxychloroquine Drugs Market Analysis and Forecast Middle East & Africa Hydroxychloroquine Drugs Market Analysis and Forecast Competition Landscape
Used to treat and manage a number of conditions such as rheumatoid arthritis and the autoimmune disease called lupus, hydroxychloroquine is seen as a wonder drug by patients suffering from these painful health issues. The antimalarial is now seeing an increase in demand from certain countries as they direct efforts towards treating COVID-19, the pandemic which is being seen as a human and humanitarian crisis. Clinical trials are underway and results of these will ascertain demand for the drug for prevention and cure of the deadly viral infection.
As per Transparency Market Research, an increased number of people suffering from arthritis and lupus will lead to growth in the hydroxychloroquine drugs market from 2019 to 2027. And, due to massive use in clinical studies being carried out in a number of R&D facilities universities and pharmaceutical companies - a significant demand is arising for the drug. The much critical and powerful hydroxychloroquine drugs are gaining increased attention in the current times owing to results from a French Study that states these are effective in treating Coronavirus infection, plaguing the planet.
Innovation and R&D are areas that are highly focused on by a number of notable players in order to drive the market forward. Hydroxychloroquine drugs market is seeing elevated demand in its landscape owing to a number of factors. A major booster as of now is now is its association with the COVID 19 treatment and prevention approvals for the same are yet to arrive from the FDA. Coronavirus positive cases have crossed the one million mark and about 100,000 people have lost their lives to this deadly disease.
India, a major producer and exporter of hydroxychloroquine is ramping up production to meet increased demand from a number of other countries, including the United States of America, to which it is giving away about 3 million tablets of the drug, and nine metric tons of API Active Pharmaceutical Ingredient. Some of the leading Indian manufacturers in the market landscape are Intas Pharmaceuticals, McW Healthcare of Indore, Macleods Pharmaceuticals, and Cipla. Some of the prominent players operating in the global hydroxychloroquine drugs market are the following - Novartis International AG, Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Ltd., Prasco Laboratories, Cardinal Health, Concordia Pharmaceuticals Inc.
To know more about us, please visit our website www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com Thank You